Tarek El Hoss Named Sr. Vice President of Market Development and Sales at MedX

August 3, 2022
Tarek El Hoss Named Sr Vice President of Market Development and Sales at MedX image

Mr. El Hoss will oversee strategic global growth initiatives and will be responsible for the deployment of market development strategies to impact immediate revenue generation and growth.

Tarek El Hoss is MedX Health Corp.’s New Senior Vice President, Market Development and Sales. 

Mr. El Hoss will oversee strategic global growth initiatives and will be responsible for the deployment of market development strategies to impact immediate revenue generation and growth.

Mr. El Hoss has more than 20 years of demonstrated success in the medical technology industry, including a lengthy tenure as Business Director, Middle East, Africa, Central Asia and Turkey for Medtronic where he was responsible for implementing and driving sales strategies while establishing distribution channels and launching new products throughout his geography of responsibility.

“Over the past year, we’ve announced commercial partnerships to make our DermSecure skin screening technology available to serve patients throughout Europe, the Middle East and Canada,” says MedX President and CEO Naman Demaghlatrous, in a news release. “Tarek’s extensive knowledge of the global medical technology marketplace and proven expertise in establishing country specific go-to-market strategies will be crucial to the next phase of our company’s growth and we’re delighted to have him join our team.”

“I am excited to join a dynamic team that is driven by a global mindset,” says Mr. El Hoss. “Leveraging and strengthening our existing partnerships while seeking out and building others will improve access to our best-in-class, innovative teledermatology platform for patients around the world. I am looking forward to expanding MedX’s international footprint and offering a solution to improving patient outcomes at the same time.”

MedX’s telemedicine platform allows health-care practitioners to quickly and accurately assess suspicious moles, lesions and other skin conditions via its image-capture technology, SIAscopy, and its secure, cloud-based patient management system, DermSecure, which transmits and stores patient data throughout the assessment process. MedX’s SIAscopy is the only technology that captures five images, including four spectrophotometric images 2mm below the skin’s surface. 

Facebook Comments

Register

We’re glad to see you’re enjoying PracticalDermatology…
but how about a more personalized experience?

Register for free